High Deliverability of a Midostaurin Triplet Regimen Incorporating Venetoclax and Low Dose Cytarabine in Non-Adverse Cytogenetic Risk Acute Myeloid Leukaemia: A Sub-Analysis of the Australasian Leukaemia Lymphoma Group (ALLG) Intervene Study

Chong Chyn Chua, Natasha S Anstee, Anoop Kumar Enjeti, Devendra Hiwase, Paula Marlton, Ashish Bajel, Shuh Ying Tan, Edward S. Morris, Chun-Kei-Kris Ma, Carolyn Grove, Julian Cooney, Ashanka Beligaswatte, Rachel M Koldej, Stephen B Ting, Travis Perera, Amanda Johnston, John Reynolds, David Ritchie, Andrew H Wei

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)3362-3364
Number of pages3
Issue numberSupplement 1
Publication statusPublished - 15 Nov 2022
EventAnnual Meeting and Exposition of the American-Society-of-Hematology (ASH) 2022 - New Orleans, United States of America
Duration: 10 Dec 202213 Dec 2022
Conference number: 64th
https://www.sciencedirect.com/journal/blood/vol/140/suppl/S1 (Meeting abstract published in Supplementary Issue of Blood)

Cite this